These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 9499991)
21. Hepatitis C virus core protein: an update on its molecular biology, cellular functions and clinical implications. Irshad M; Dhar I Med Princ Pract; 2006; 15(6):405-16. PubMed ID: 17047346 [TBL] [Abstract][Full Text] [Related]
22. Clinical presentation of GB-C virus infection in drug abusers with chronic hepatitis C. Goeser T; Seipp S; Wahl R; Müller HM; Stremmel W; Theilmann L J Hepatol; 1997 Mar; 26(3):498-502. PubMed ID: 9075655 [TBL] [Abstract][Full Text] [Related]
23. Consensus guidelines for the management of hepatitis C infection. Consensus Guidelines Committee for the Management of Hepatitis C Infection Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186 [TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of hepatitis C virus activity in vivo in different groups of untreated patients. Manzin A; Solforosi L; Giostra F; Bianchi FB; Bruno S; Rossi S; Gabrielli A; Candela M; Petrelli E; Clementi M Arch Virol; 1997; 142(3):465-72. PubMed ID: 9349293 [TBL] [Abstract][Full Text] [Related]
25. Pathophysiology of hepatitis C virus infection. Camps J; Córdoba J; Esteban JI Pathol Biol (Paris); 1995 Oct; 43(8):691-702. PubMed ID: 8745591 [TBL] [Abstract][Full Text] [Related]
29. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Gottwein JM; Scheel TK; Jensen TB; Lademann JB; Prentoe JC; Knudsen ML; Hoegh AM; Bukh J Hepatology; 2009 Feb; 49(2):364-77. PubMed ID: 19148942 [TBL] [Abstract][Full Text] [Related]
34. [Prediction of the outcome of IFN therapy in type C chronic hepatitis from serological grouping of hepatitis C virus]. Sakai A; Yanagi M; Unoura M; Kobayashi K Nihon Rinsho; 1994 Jul; 52(7):1759-62. PubMed ID: 7521415 [TBL] [Abstract][Full Text] [Related]
35. Patterns of hepatitis C viremia in patients receiving hemodialysis. Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941 [TBL] [Abstract][Full Text] [Related]
36. The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8. Clément S; Pascarella S; Conzelmann S; Gonelle-Gispert C; Guilloux K; Negro F J Hepatol; 2010 May; 52(5):635-43. PubMed ID: 20347177 [TBL] [Abstract][Full Text] [Related]
37. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia. Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052 [TBL] [Abstract][Full Text] [Related]
38. Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan. Yu ML; Chuang WL; Chen SC; Dai CY; Hou C; Wang JH; Lu SN; Huang JF; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY J Med Virol; 2001 Sep; 65(1):58-65. PubMed ID: 11505444 [TBL] [Abstract][Full Text] [Related]
39. Perinatal transmission of hepatitis G virus (GB virus type C) and hepatitis C virus infections--a comparison. Wejstål R; Månson AS; Widell A; Norkrans G Clin Infect Dis; 1999 Apr; 28(4):816-21. PubMed ID: 10825044 [TBL] [Abstract][Full Text] [Related]
40. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end. Han JH; Shyamala V; Richman KH; Brauer MJ; Irvine B; Urdea MS; Tekamp-Olson P; Kuo G; Choo QL; Houghton M Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1711-5. PubMed ID: 1705704 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]